Since altered IRAK signaling has been associated with the development of myeloid leukemia and breast cancer and since we demonstrate here that CMCE modulates IRAK signaling in THP-1 AML cells, we hypothesized that CMCE might show cytotoxic effects in AML- and breast cancer-derived cell lines. The gene discussed is IRAK1; the disease is myeloid leukemia.